v3.10.0.1
Condensed Consolidated Interim Balance Sheets - USD ($)
Sep. 30, 2018
Mar. 31, 2018
Current    
Cash and cash equivalents $ 305,757 $ 507,311
Accounts receivable, net of allowance for doubtful accounts of $17,699 (March 31, 2018 - $19,694) 517,758 212,730
Prepaid expenses and other receivables (Note 5) 851,179 433,655
Inventories (Note 6) 192,626 237,443
Due from related parties (Note 9(a)) 18,913 18,897
Total Current Assets 1,886,233 1,410,036
Equipment (Note 7) 139,380 159,961
Technology and other assets (Note 4) 4,566,351 4,706,719
Goodwill 22,308,275 22,308,275
Total Assets 28,900,239 28,584,991
Current    
Accounts payable (Notes 9(b) and 13) 906,438 724,673
Accrued liabilities (Note 9(b)) 962,185 1,529,505
Customer advances 0 800
Demand loans (Note 8) 0 51,479
Deferred revenue 134,161 122,667
Shares to be issued, stock options and warrants (Notes 10, 11 and 12) 0 5,692,853
Total Current Liabilities 2,002,784 8,121,977
Shareholders' Equity    
Preferred Stock, par value $0.001; Authorized - 10,000,000; Special Voting Preferred Stock, par value $0.001 - Authorized, issued and outstanding - 1 (March 31, 2018 – 1) 0 0
Common Shares, par value $0.001; Authorized - 500,000,000 (March 31, 2018 – 250,000,000); Issued and outstanding - 2,337,462 and 273,574 Exchangeable Shares (March 31, 2018 – 1,368,856 and 295,146 Exchangeable Shares) 2,611 1,664
Additional paid in capital 67,379,122 56,195,541
Deficit (40,526,427) (35,776,340)
Accumulated other comprehensive income 42,149 42,149
Total Shareholders' Equity 26,897,455 20,463,014
Total Liabilities and Shareholders' Equity $ 28,900,239 $ 28,584,991

Source

v3.10.0.1
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Sales $ 547,085 $ 221,847 $ 1,048,418 $ 309,367
Cost of Sales 384,073 59,825 637,236 89,125
Gross Margin 163,012 162,022 411,182 220,242
Operating expenses        
Sales and marketing 427,325 435,294 969,984 880,817
Research and development 679,049 715,400 1,355,792 1,401,309
General and administrative 931,477 1,505,528 1,910,956 2,133,134
Share-based compensation expense (Note 11) 439,328 762,208 1,034,740 1,013,256
Amortization (Note 4) 69,315 76,985 140,368 169,934
Depreciation (Note 7) 16,626 23,820 34,221 48,372
Total operating expenses 2,563,120 3,519,235 5,446,061 5,646,822
Other (income) expenses        
Foreign exchange (27,872) 15,595 (69,006) 114,156
Accretion expense (Note 8) 1,970,167 74,073 2,104,418 74,073
Fair value adjustment (Note 8) (382,010) 0 (337,923) 0
Gain on mark to market revaluation (Note 10) 0 0 (2,048,697) 0
Other expense 22,712 168,480 60,132 241,068
Total other expenses (income) 1,582,997 258,148 (291,076) 429,297
Net loss and comprehensive loss for the period $ (3,983,105) $ (3,615,361) $ (4,743,803) $ (5,855,877)
Loss per share - basic and diluted $ (1.62) $ (5.33) $ (2.02) $ (8.84)
Loss per share - diluted $ (1.62) $ (5.33) $ (2.02) $ (8.84)
Weighted average number of shares outstanding – basic 2,459,169 678,631 2,351,587 662,237
Weighted average number of shares outstanding – diluted 2,459,169 678,631 2,351,587 662,237

Source

v3.10.0.1
Condensed Consolidated Interim Statements of Cash Flows - USD ($)
6 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating activities    
Net loss for the period $ (4,743,803) $ (5,855,877)
Adjustment for items not affecting cash    
Depreciation 34,221 48,372
Amortization 140,368 169,934
Interest expense 57,716 234,463
Share based compensation expense 1,034,740 1,013,256
Shares issued for services 0 60,000
Accretion expense 2,104,418 74,073
Fair value adjustment (337,923) 0
Gain on mark to market revaluation (2,048,697) 0
Allowance for doubtful accounts (1,995) (16,349)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities (3,760,955) (4,272,128)
Changes in non-cash working capital items    
Accounts receivable (303,033) 363,056
Prepaid expenses and other receivables (417,524) 58,760
Due from related parties (16) (698)
Inventories 44,817 (3,193)
Accounts payable 181,765 172,634
Accrued liabilities (567,320) 644,955
Customer advances (800) (12,462)
Deferred revenue 11,494 (10,773)
Net cash (used in) operating activities (4,811,572) (3,059,849)
Investing activities    
Acquisition of equipment (13,640) (17,182)
Net cash (used in) investing activities (13,640) (17,182)
Financing activities    
Proceeds from convertible loans 4,676,633 1,598,715
Proceeds on exercise of warrants 0 1,125,038
Repayment of Promissory notes principal 0 (12,319)
Repayment of Promissory notes interest 0 (41,973)
Repayment of Demand notes principal (50,000) 0
Repayment of Demand notes interest (2,975) 0
Net cash provided by financing activities 4,623,658 2,669,461
Net decrease in cash and cash equivalents for the period (201,554) (407,570)
Cash and cash equivalents, beginning of period 507,311 543,650
Cash and cash equivalents, end of period $ 305,757 $ 136,080

Source